TRIO PHARMA ApS: Financial statements 2024
CVR: 36499281
Source: annual report 2024, Danish Business Authority
01/05/2023 – 30/04/2024
TRIO PHARMA ApS (CVR 36499281) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -288,579 and a net result of DKK -489,664 compared with DKK -889,359 the year before. Equity in the 2024 report amounted to DKK -1,422,653. The company had 1 employee in the financial year.
- Gross Profit
- DKK -288,579
- Profit/Loss
- DKK -489,664
- Equity
- DKK -1,422,653
- Total Assets
- DKK 1,296,425
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -289 t. | -490 t. | -1.4 mio. | 1 |
| 2023 | - | -491 t. | -889 t. | -933 t. | 2 |
| 2022 | - | -423 t. | 9 mio. | -44 t. | 1 |
| 2021 | - | 361 t. | -152 t. | -1.3 mio. | 1 |
| 2020 | - | 85 t. | -361 t. | -1.1 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout TRIO PHARMA ApS
TRIO PHARMA ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christian Bo Ratje. The board consists of Michael John Ratje (chair), Christian Bo Ratje and Kirstine Laura Ratje-Johansen. The company is owned by STINE RATJE HOLDING ApS and CHRISTIAN RATJE HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK -411,555 and a net result of DKK -1,170,880 compared with DKK -489,664 the year before. Equity in the 2025 report amounted to DKK -2,593,533.